BlueLinx Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BlueLinx stock.
View analyst ratings for BlueLinx or view top-rated stocks.

Wall Street analysts have given BlueLinx a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BlueLinx wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

BlueLinx saw a increase in short interest in March. As of March 15th, there was short interest totaling 159,000 shares, an increase of 38.9% from the February 28th total of 114,500 shares. Based on an average daily trading volume, of 131,600 shares, the short-interest ratio is currently 1.2 days. Approximately 1.8% of the company's stock are short sold.
View BlueLinx's Short Interest.

BlueLinx is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for BlueLinx.

BlueLinx Holdings Inc. (NYSE:BXC) released its quarterly earnings results on Thursday, March, 4th. The construction company reported $2.04 EPS for the quarter, topping the consensus estimate of $0.66 by $1.38. The construction company had revenue of $865.42 million for the quarter. BlueLinx had a net margin of 1.79% and a negative trailing twelve-month return on equity of 583.03%.
View BlueLinx's earnings history.

BlueLinx's stock was trading at $5.53 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BXC stock has increased by 735.4% and is now trading at $46.20.
View which stocks have been most impacted by COVID-19.

3 brokerages have issued 1 year price objectives for BlueLinx's stock. Their forecasts range from $25.00 to $61.00. On average, they expect BlueLinx's share price to reach $43.00 in the next twelve months. This suggests that the stock has a possible downside of 6.9%.
View analysts' price targets for BlueLinx or view top-rated stocks among Wall Street analysts.

56 employees have rated BlueLinx CEO Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among BlueLinx's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to BlueLinx include Fastenal (FAST), United Rentals (URI), W.W. Grainger (GWW), Watsco (WSO), Air Lease (AL), MSC Industrial Direct (MSM), WESCO International (WCC), Beacon Roofing Supply (BECN), Applied Industrial Technologies (AIT), GATX (GATX), Rush Enterprises (RUSHA), Kaman (KAMN), Textainer Group (TGH), H&E Equipment Services (HEES) and MRC Global (MRC).
View all of BXC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), Nautilus (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

BlueLinx's stock is owned by many different institutional and retail investors. Top institutional shareholders include Hennessy Advisors Inc. (0.81%), Exchange Traded Concepts LLC (0.13%) and Carroll Financial Associates Inc. (0.01%). Company insiders that own BlueLinx stock include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC and Shyam K Reddy.
View institutional ownership trends for BlueLinx.

BXC stock was sold by a variety of institutional investors in the last quarter, including Carroll Financial Associates Inc.. Company insiders that have sold BlueLinx company stock in the last year include Kim S Fennebresque, and Nokomis Capital, LLC.
View insider buying and selling activity for BlueLinx or view top insider-selling stocks.

BXC stock was bought by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., and Exchange Traded Concepts LLC. Company insiders that have bought BlueLinx stock in the last two years include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, and Shyam K Reddy.
View insider buying and selling activity for BlueLinx or or view top insider-buying stocks.

Shares of BXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BXC stock can currently be purchased for approximately $46.20.

BlueLinx has a market capitalization of $437.42 million and generates $2.64 billion in revenue each year. The construction company earns $-17,660,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis.

BlueLinx employs 2,079 workers across the globe.

The official website for BlueLinx is www.bluelinxco.com.

BlueLinx is headquartered at 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067.

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The construction company can be reached via phone at 770-953-7000 or via email at [email protected]